 Makoto Miyazaki
Concepts (480)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stearoyl-CoA Desaturase | 37 | 2015 | 54 | 4.680 |
Why?
| | Vascular Calcification | 9 | 2022 | 108 | 4.360 |
Why?
| | Renal Insufficiency, Chronic | 8 | 2022 | 488 | 2.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 9 | 2018 | 195 | 1.870 |
Why?
| | Atherosclerosis | 8 | 2021 | 341 | 1.840 |
Why?
| | Activating Transcription Factor 4 | 5 | 2021 | 18 | 1.780 |
Why?
| | Endoplasmic Reticulum | 5 | 2021 | 235 | 1.760 |
Why?
| | Transcription Factor CHOP | 4 | 2018 | 28 | 1.660 |
Why?
| | Bile Acids and Salts | 3 | 2018 | 172 | 1.560 |
Why?
| | Autophagy | 4 | 2022 | 236 | 1.430 |
Why?
| | Fatty Acids | 18 | 2018 | 386 | 1.350 |
Why?
| | Liver | 20 | 2019 | 1693 | 1.350 |
Why?
| | Endoplasmic Reticulum Stress | 4 | 2021 | 92 | 1.270 |
Why?
| | Calcinosis | 4 | 2014 | 244 | 1.090 |
Why?
| | Mice | 63 | 2022 | 15087 | 1.050 |
Why?
| | Lipids | 9 | 2018 | 589 | 1.040 |
Why?
| | Membrane Proteins | 3 | 2022 | 1033 | 0.970 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2018 | 193 | 0.970 |
Why?
| | Deoxycholic Acid | 3 | 2022 | 15 | 0.840 |
Why?
| | Animals | 71 | 2022 | 32162 | 0.830 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 13 | 0.820 |
Why?
| | Leptin | 9 | 2010 | 211 | 0.810 |
Why?
| | Stearic Acids | 2 | 2012 | 12 | 0.800 |
Why?
| | Mice, Knockout | 25 | 2019 | 2609 | 0.730 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2018 | 239 | 0.710 |
Why?
| | Vascular Diseases | 2 | 2014 | 230 | 0.680 |
Why?
| | Starvation | 1 | 2019 | 21 | 0.660 |
Why?
| | Isoenzymes | 6 | 2006 | 287 | 0.650 |
Why?
| | Cyclin T | 1 | 2018 | 2 | 0.650 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2018 | 9 | 0.640 |
Why?
| | Lipid Metabolism | 13 | 2018 | 449 | 0.610 |
Why?
| | Kidney Diseases | 4 | 2019 | 355 | 0.590 |
Why?
| | Apolipoproteins E | 4 | 2014 | 81 | 0.570 |
Why?
| | eIF-2 Kinase | 2 | 2013 | 24 | 0.550 |
Why?
| | Coronary Vessels | 2 | 2022 | 230 | 0.550 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 389 | 0.550 |
Why?
| | Mice, Inbred C57BL | 21 | 2020 | 4780 | 0.550 |
Why?
| | Cholesterol | 7 | 2016 | 368 | 0.540 |
Why?
| | Lipogenesis | 4 | 2012 | 57 | 0.540 |
Why?
| | Coronary Artery Disease | 2 | 2022 | 613 | 0.520 |
Why?
| | Phosphatidylethanolamines | 1 | 2015 | 66 | 0.510 |
Why?
| | Triglycerides | 10 | 2014 | 471 | 0.460 |
Why?
| | Osteogenesis | 4 | 2021 | 184 | 0.460 |
Why?
| | Metabolomics | 1 | 2018 | 536 | 0.440 |
Why?
| | Kidney | 7 | 2021 | 1210 | 0.430 |
Why?
| | Blood Vessels | 2 | 2011 | 181 | 0.430 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 3 | 2019 | 32 | 0.400 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 4 | 2020 | 34 | 0.390 |
Why?
| | Cisplatin | 3 | 2020 | 263 | 0.390 |
Why?
| | Dietary Fats | 4 | 2007 | 291 | 0.380 |
Why?
| | Cells, Cultured | 11 | 2019 | 3914 | 0.360 |
Why?
| | Gene Expression Regulation | 7 | 2020 | 2365 | 0.360 |
Why?
| | Signal Transduction | 13 | 2022 | 4528 | 0.360 |
Why?
| | Fatty Liver | 3 | 2012 | 217 | 0.360 |
Why?
| | Transcription Factors | 5 | 2006 | 1535 | 0.350 |
Why?
| | DNA-Binding Proteins | 6 | 2008 | 1318 | 0.340 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 1724 | 0.330 |
Why?
| | Inflammation | 6 | 2021 | 2502 | 0.330 |
Why?
| | Protein Isoforms | 5 | 2019 | 339 | 0.320 |
Why?
| | Mice, Transgenic | 7 | 2018 | 1971 | 0.320 |
Why?
| | Macrophages | 6 | 2021 | 1282 | 0.320 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1138 | 0.310 |
Why?
| | Phosphorylation | 8 | 2018 | 1562 | 0.310 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 8 | 2011 | 54 | 0.310 |
Why?
| | Male | 35 | 2021 | 56117 | 0.310 |
Why?
| | Adiposity | 3 | 2010 | 468 | 0.300 |
Why?
| | Oleic Acid | 4 | 2009 | 30 | 0.300 |
Why?
| | Orphan Nuclear Receptors | 5 | 2012 | 14 | 0.300 |
Why?
| | Mice, Inbred DBA | 2 | 2018 | 173 | 0.290 |
Why?
| | AMP-Activated Protein Kinases | 5 | 2022 | 175 | 0.280 |
Why?
| | Myocardium | 4 | 2010 | 929 | 0.280 |
Why?
| | Insulin Resistance | 3 | 2009 | 1078 | 0.270 |
Why?
| | Transcription, Genetic | 3 | 2020 | 1317 | 0.260 |
Why?
| | Receptors, LDL | 2 | 2018 | 41 | 0.260 |
Why?
| | Fatty Acid Desaturases | 1 | 2006 | 33 | 0.260 |
Why?
| | Obesity | 7 | 2010 | 2523 | 0.260 |
Why?
| | Fructokinases | 2 | 2016 | 29 | 0.250 |
Why?
| | Energy Metabolism | 3 | 2008 | 713 | 0.240 |
Why?
| | Epithelial Cells | 3 | 2019 | 961 | 0.240 |
Why?
| | Diet | 4 | 2021 | 1074 | 0.240 |
Why?
| | Humans | 33 | 2022 | 115879 | 0.240 |
Why?
| | Cell Line | 5 | 2018 | 2657 | 0.230 |
Why?
| | Glomerulonephritis | 2 | 2021 | 45 | 0.230 |
Why?
| | Fructose | 1 | 2004 | 100 | 0.230 |
Why?
| | Liver X Receptors | 5 | 2012 | 30 | 0.220 |
Why?
| | Kidney Tubules, Proximal | 2 | 2022 | 113 | 0.220 |
Why?
| | Isothiocyanates | 1 | 2022 | 2 | 0.210 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2022 | 7 | 0.210 |
Why?
| | Adipose Tissue | 3 | 2010 | 553 | 0.210 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2012 | 275 | 0.210 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2022 | 9 | 0.210 |
Why?
| | Lysosomes | 2 | 2021 | 125 | 0.200 |
Why?
| | Acute Kidney Injury | 2 | 2020 | 647 | 0.200 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2016 | 420 | 0.200 |
Why?
| | Folate Receptor 2 | 1 | 2021 | 6 | 0.200 |
Why?
| | Parathyroid Hormone | 1 | 2022 | 95 | 0.200 |
Why?
| | Multienzyme Complexes | 4 | 2005 | 64 | 0.200 |
Why?
| | Phosphates | 1 | 2022 | 160 | 0.190 |
Why?
| | Biomarkers | 4 | 2021 | 3474 | 0.190 |
Why?
| | Toxins, Biological | 1 | 2020 | 11 | 0.190 |
Why?
| | Kidney Glomerulus | 2 | 2019 | 102 | 0.190 |
Why?
| | Skin | 1 | 2005 | 668 | 0.190 |
Why?
| | Fibroblast Growth Factors | 1 | 2022 | 162 | 0.190 |
Why?
| | Anticholesteremic Agents | 2 | 2012 | 129 | 0.190 |
Why?
| | Spectrum Analysis, Raman | 2 | 2011 | 41 | 0.180 |
Why?
| | Homeostasis | 2 | 2021 | 577 | 0.180 |
Why?
| | Podocytes | 2 | 2019 | 44 | 0.180 |
Why?
| | Insulin | 7 | 2009 | 2084 | 0.180 |
Why?
| | Disease Models, Animal | 10 | 2019 | 3587 | 0.180 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2020 | 9 | 0.180 |
Why?
| | Amino Acid Sequence | 3 | 2019 | 2003 | 0.180 |
Why?
| | Tissue Distribution | 3 | 2007 | 324 | 0.180 |
Why?
| | Gene Knockout Techniques | 2 | 2018 | 99 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 113 | 0.170 |
Why?
| | Down-Regulation | 4 | 2008 | 605 | 0.170 |
Why?
| | Cattle | 3 | 2011 | 935 | 0.170 |
Why?
| | Hepatocytes | 2 | 2019 | 197 | 0.170 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 361 | 0.170 |
Why?
| | Heat-Shock Response | 1 | 2019 | 46 | 0.170 |
Why?
| | Tretinoin | 1 | 2020 | 123 | 0.170 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2005 | 86 | 0.160 |
Why?
| | Intestine, Small | 1 | 2020 | 125 | 0.160 |
Why?
| | Amino Acids | 2 | 2021 | 456 | 0.160 |
Why?
| | Fatty Acids, Monounsaturated | 4 | 2009 | 47 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2021 | 137 | 0.160 |
Why?
| | Mitochondria, Liver | 2 | 2012 | 66 | 0.160 |
Why?
| | Receptors, Fc | 1 | 2019 | 45 | 0.160 |
Why?
| | Carrier Proteins | 2 | 2021 | 703 | 0.160 |
Why?
| | Serum Albumin | 1 | 2019 | 135 | 0.160 |
Why?
| | Osteopontin | 1 | 2018 | 32 | 0.160 |
Why?
| | Disease Progression | 3 | 2021 | 2423 | 0.150 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2018 | 68 | 0.150 |
Why?
| | Fever | 1 | 2019 | 280 | 0.150 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2019 | 126 | 0.150 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 174 | 0.150 |
Why?
| | Interleukin-33 | 1 | 2017 | 40 | 0.150 |
Why?
| | Chelating Agents | 1 | 2017 | 71 | 0.150 |
Why?
| | Adaptive Immunity | 1 | 2018 | 157 | 0.140 |
Why?
| | Gene Knockdown Techniques | 3 | 2014 | 303 | 0.140 |
Why?
| | Ion Pumps | 1 | 2016 | 1 | 0.140 |
Why?
| | Phosphorus | 1 | 2017 | 81 | 0.140 |
Why?
| | Cell Proliferation | 3 | 2020 | 2196 | 0.140 |
Why?
| | Mice, Mutant Strains | 4 | 2012 | 271 | 0.140 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 804 | 0.140 |
Why?
| | Mitochondria | 3 | 2019 | 750 | 0.140 |
Why?
| | Adipocytes, White | 2 | 2022 | 17 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 377 | 0.140 |
Why?
| | Dietary Carbohydrates | 2 | 2007 | 136 | 0.140 |
Why?
| | Heart | 4 | 2010 | 612 | 0.140 |
Why?
| | Base Sequence | 4 | 2007 | 2121 | 0.130 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1551 | 0.130 |
Why?
| | Muscle, Smooth | 1 | 2016 | 150 | 0.130 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 346 | 0.130 |
Why?
| | Cell Differentiation | 3 | 2012 | 1709 | 0.130 |
Why?
| | Carbohydrate Metabolism | 2 | 2007 | 50 | 0.130 |
Why?
| | Protein Binding | 3 | 2018 | 1918 | 0.130 |
Why?
| | Diet, Fat-Restricted | 2 | 2006 | 73 | 0.130 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1130 | 0.130 |
Why?
| | Albuminuria | 1 | 2016 | 164 | 0.130 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2016 | 185 | 0.130 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 555 | 0.130 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2018 | 209 | 0.130 |
Why?
| | Hydrocarbons, Fluorinated | 2 | 2012 | 9 | 0.130 |
Why?
| | Metabolic Syndrome | 3 | 2008 | 323 | 0.120 |
Why?
| | Tetraspanins | 1 | 2014 | 15 | 0.120 |
Why?
| | Immunoglobulin G | 1 | 2019 | 782 | 0.120 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2014 | 39 | 0.120 |
Why?
| | Ketocholesterols | 1 | 2014 | 8 | 0.120 |
Why?
| | Bone Marrow | 1 | 2016 | 248 | 0.120 |
Why?
| | Osteoblasts | 2 | 2012 | 106 | 0.120 |
Why?
| | Ezetimibe | 1 | 2014 | 24 | 0.120 |
Why?
| | Azetidines | 1 | 2014 | 31 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 789 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 504 | 0.120 |
Why?
| | Simvastatin | 1 | 2014 | 59 | 0.120 |
Why?
| | Dehydration | 1 | 2013 | 38 | 0.110 |
Why?
| | Bone Density | 1 | 2017 | 432 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1725 | 0.110 |
Why?
| | HeLa Cells | 4 | 2012 | 567 | 0.110 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 688 | 0.110 |
Why?
| | Muscle, Skeletal | 5 | 2005 | 1459 | 0.110 |
Why?
| | Cholesterol Ester Transfer Proteins | 1 | 2012 | 17 | 0.110 |
Why?
| | Body Weight | 6 | 2010 | 868 | 0.100 |
Why?
| | Benzoates | 1 | 2012 | 38 | 0.100 |
Why?
| | Case-Control Studies | 3 | 2017 | 3054 | 0.100 |
Why?
| | Catechin | 1 | 2012 | 23 | 0.100 |
Why?
| | Lipoproteins, HDL | 1 | 2012 | 76 | 0.100 |
Why?
| | Nicorandil | 1 | 2012 | 10 | 0.100 |
Why?
| | Isoxazoles | 1 | 2012 | 56 | 0.100 |
Why?
| | Minerals | 1 | 2012 | 37 | 0.100 |
Why?
| | Oxidation-Reduction | 5 | 2010 | 924 | 0.100 |
Why?
| | Nitric Oxide Donors | 1 | 2012 | 15 | 0.100 |
Why?
| | Biomedical Research | 1 | 2018 | 589 | 0.100 |
Why?
| | RNA, Messenger | 7 | 2018 | 2581 | 0.100 |
Why?
| | DNA Primers | 3 | 2007 | 514 | 0.100 |
Why?
| | Female | 17 | 2022 | 60082 | 0.100 |
Why?
| | Mitochondrial Diseases | 1 | 2012 | 77 | 0.100 |
Why?
| | Risk Factors | 3 | 2022 | 8715 | 0.100 |
Why?
| | Antioxidants | 2 | 2012 | 534 | 0.100 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2011 | 33 | 0.100 |
Why?
| | Sulfonamides | 2 | 2012 | 447 | 0.100 |
Why?
| | Aorta | 2 | 2012 | 354 | 0.100 |
Why?
| | Rats | 4 | 2021 | 5035 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 962 | 0.100 |
Why?
| | Models, Biological | 5 | 2006 | 1647 | 0.100 |
Why?
| | Molecular Imaging | 1 | 2011 | 52 | 0.100 |
Why?
| | Glucose | 2 | 2007 | 903 | 0.090 |
Why?
| | Plaque, Atherosclerotic | 1 | 2011 | 43 | 0.090 |
Why?
| | Middle Aged | 5 | 2022 | 27085 | 0.090 |
Why?
| | Etoposide | 1 | 2011 | 149 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2018 | 2807 | 0.090 |
Why?
| | Alkaline Phosphatase | 1 | 2011 | 144 | 0.090 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 1891 | 0.090 |
Why?
| | Chenodeoxycholic Acid | 1 | 2010 | 12 | 0.090 |
Why?
| | Cholesterol, HDL | 2 | 2012 | 185 | 0.090 |
Why?
| | Aging | 2 | 2019 | 1635 | 0.090 |
Why?
| | Hypertriglyceridemia | 2 | 2008 | 34 | 0.090 |
Why?
| | Fibroblasts | 1 | 2014 | 839 | 0.090 |
Why?
| | Mice, Obese | 3 | 2006 | 52 | 0.090 |
Why?
| | Diacylglycerol O-Acyltransferase | 2 | 2006 | 3 | 0.090 |
Why?
| | Blotting, Northern | 3 | 2005 | 194 | 0.080 |
Why?
| | Agouti Signaling Protein | 1 | 2009 | 2 | 0.080 |
Why?
| | Diabetic Nephropathies | 1 | 2012 | 234 | 0.080 |
Why?
| | Cholic Acids | 1 | 2008 | 17 | 0.080 |
Why?
| | Microscopy | 1 | 2010 | 124 | 0.080 |
Why?
| | Hypercholesterolemia | 2 | 2006 | 92 | 0.080 |
Why?
| | Ceramides | 2 | 2010 | 96 | 0.080 |
Why?
| | Lung Neoplasms | 2 | 2020 | 2206 | 0.080 |
Why?
| | Hyperlipidemia, Familial Combined | 1 | 2008 | 3 | 0.080 |
Why?
| | Lipocalin-2 | 2 | 2020 | 62 | 0.080 |
Why?
| | Transgenes | 2 | 2006 | 169 | 0.080 |
Why?
| | Phosphatidylcholines | 2 | 2008 | 134 | 0.080 |
Why?
| | Receptor, Insulin | 2 | 2006 | 93 | 0.080 |
Why?
| | Acyltransferases | 2 | 2005 | 46 | 0.080 |
Why?
| | Time Factors | 4 | 2019 | 6182 | 0.080 |
Why?
| | Tumor Burden | 2 | 2020 | 261 | 0.080 |
Why?
| | Microsomes | 2 | 2007 | 24 | 0.080 |
Why?
| | Glycogen | 2 | 2004 | 52 | 0.070 |
Why?
| | Mycological Typing Techniques | 1 | 2007 | 1 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2009 | 344 | 0.070 |
Why?
| | Gluconeogenesis | 1 | 2007 | 60 | 0.070 |
Why?
| | Sucrose | 1 | 2007 | 91 | 0.070 |
Why?
| | Histoplasma | 1 | 2007 | 14 | 0.070 |
Why?
| | Histoplasmosis | 1 | 2007 | 16 | 0.070 |
Why?
| | Animal Feed | 2 | 2004 | 50 | 0.070 |
Why?
| | Adipose Tissue, Brown | 2 | 2004 | 68 | 0.070 |
Why?
| | Blood Pressure | 4 | 2016 | 1537 | 0.070 |
Why?
| | Pedigree | 1 | 2008 | 474 | 0.070 |
Why?
| | Aged | 3 | 2022 | 19296 | 0.070 |
Why?
| | Mutation | 5 | 2018 | 3371 | 0.070 |
Why?
| | Lipolysis | 2 | 2022 | 38 | 0.070 |
Why?
| | Blotting, Western | 5 | 2007 | 1153 | 0.070 |
Why?
| | Choline-Phosphate Cytidylyltransferase | 1 | 2005 | 3 | 0.060 |
Why?
| | Colitis | 1 | 2008 | 226 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2006 | 2796 | 0.060 |
Why?
| | Receptors, Retinoic Acid | 2 | 2020 | 50 | 0.060 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2004 | 2 | 0.060 |
Why?
| | Structure-Activity Relationship | 2 | 2018 | 511 | 0.060 |
Why?
| | Up-Regulation | 2 | 2004 | 824 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2590 | 0.060 |
Why?
| | Thermogenesis | 1 | 2004 | 40 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1598 | 0.060 |
Why?
| | Lipodystrophy | 1 | 2004 | 15 | 0.060 |
Why?
| | Linoleic Acid | 1 | 2004 | 38 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2004 | 68 | 0.060 |
Why?
| | Hypothermia | 1 | 2004 | 38 | 0.060 |
Why?
| | Anti-Obesity Agents | 1 | 2004 | 45 | 0.060 |
Why?
| | Cold Temperature | 1 | 2004 | 128 | 0.060 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2003 | 12 | 0.060 |
Why?
| | Cholestasis | 1 | 2006 | 225 | 0.060 |
Why?
| | Mice, SCID | 1 | 2004 | 321 | 0.060 |
Why?
| | Animals, Newborn | 1 | 2005 | 780 | 0.050 |
Why?
| | Foam Cells | 2 | 2016 | 13 | 0.050 |
Why?
| | Culture Media, Conditioned | 2 | 2016 | 105 | 0.050 |
Why?
| | Cell Membrane | 2 | 2005 | 683 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 262 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2003 | 353 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2003 | 147 | 0.050 |
Why?
| | Sulfoxides | 1 | 2022 | 2 | 0.050 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 31 | 0.050 |
Why?
| | RNA | 2 | 2007 | 820 | 0.050 |
Why?
| | Carnitine O-Palmitoyltransferase | 3 | 2007 | 43 | 0.050 |
Why?
| | Protein Transport | 2 | 2019 | 400 | 0.050 |
Why?
| | Saccharomyces cerevisiae | 1 | 2006 | 482 | 0.050 |
Why?
| | Aminopterin | 1 | 2021 | 1 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2003 | 214 | 0.050 |
Why?
| | Apoptosis | 3 | 2020 | 2377 | 0.050 |
Why?
| | Phospholipids | 1 | 2003 | 202 | 0.050 |
Why?
| | Autophagosomes | 1 | 2021 | 19 | 0.050 |
Why?
| | Japan | 1 | 2021 | 89 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 39 | 0.050 |
Why?
| | Proteinuria | 1 | 2021 | 78 | 0.050 |
Why?
| | Biological Assay | 1 | 2021 | 114 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2005 | 796 | 0.050 |
Why?
| | Folic Acid | 1 | 2021 | 159 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 579 | 0.040 |
Why?
| | Hypophosphatemia, Familial | 1 | 2020 | 3 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 51 | 0.040 |
Why?
| | Methotrexate | 1 | 2021 | 228 | 0.040 |
Why?
| | Butadienes | 1 | 2020 | 31 | 0.040 |
Why?
| | Retinoid X Receptors | 1 | 2020 | 39 | 0.040 |
Why?
| | Vegetables | 1 | 2021 | 130 | 0.040 |
Why?
| | 2,4-Dinitrophenol | 1 | 2019 | 8 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2020 | 138 | 0.040 |
Why?
| | Oxygen | 1 | 2004 | 837 | 0.040 |
Why?
| | Kidney Medulla | 1 | 2019 | 29 | 0.040 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 550 | 0.040 |
Why?
| | Pyrimidinones | 1 | 2020 | 86 | 0.040 |
Why?
| | Nitriles | 1 | 2020 | 152 | 0.040 |
Why?
| | Liver Regeneration | 1 | 2019 | 32 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2019 | 61 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 458 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 50 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 368 | 0.040 |
Why?
| | Pyridones | 1 | 2020 | 123 | 0.040 |
Why?
| | Health Surveys | 1 | 2021 | 447 | 0.040 |
Why?
| | DNA | 1 | 2005 | 1357 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2020 | 274 | 0.040 |
Why?
| | TRPP Cation Channels | 1 | 2018 | 63 | 0.040 |
Why?
| | Odds Ratio | 1 | 2021 | 968 | 0.040 |
Why?
| | Urinary Tract | 1 | 2018 | 37 | 0.040 |
Why?
| | Weight Loss | 1 | 2002 | 633 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 181 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 605 | 0.040 |
Why?
| | In Vitro Techniques | 2 | 2012 | 1044 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 388 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2011 | 792 | 0.030 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2018 | 153 | 0.030 |
Why?
| | Mice, Knockout, ApoE | 1 | 2016 | 8 | 0.030 |
Why?
| | Dietary Fats, Unsaturated | 2 | 2006 | 21 | 0.030 |
Why?
| | RAW 264.7 Cells | 1 | 2016 | 41 | 0.030 |
Why?
| | Oxidative Stress | 2 | 2012 | 1095 | 0.030 |
Why?
| | Pyridines | 1 | 2019 | 425 | 0.030 |
Why?
| | Gene Silencing | 1 | 2016 | 176 | 0.030 |
Why?
| | Hyperlipidemias | 1 | 2016 | 123 | 0.030 |
Why?
| | Chemokine CXCL6 | 1 | 2014 | 2 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2016 | 175 | 0.030 |
Why?
| | Mice, Inbred Strains | 2 | 2006 | 399 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 272 | 0.030 |
Why?
| | Immunoblotting | 2 | 2005 | 283 | 0.030 |
Why?
| | Creatinine | 1 | 2016 | 431 | 0.030 |
Why?
| | Immunotherapy | 1 | 2018 | 481 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2336 | 0.030 |
Why?
| | Gene Expression | 3 | 2004 | 1442 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2013 | 23 | 0.030 |
Why?
| | Fatty Acid Synthases | 2 | 2005 | 24 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1871 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 24 | 0.030 |
Why?
| | Pregnancy | 1 | 2005 | 5555 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 445 | 0.030 |
Why?
| | Mice, Nude | 1 | 2014 | 639 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 414 | 0.030 |
Why?
| | beta Catenin | 1 | 2014 | 220 | 0.030 |
Why?
| | Uric Acid | 1 | 2013 | 150 | 0.030 |
Why?
| | Macaca fascicularis | 1 | 2012 | 51 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 2012 | 41 | 0.030 |
Why?
| | Cytochromes c | 1 | 2012 | 62 | 0.030 |
Why?
| | Streptozocin | 1 | 2012 | 16 | 0.030 |
Why?
| | Blood Glucose | 3 | 2006 | 1826 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1169 | 0.030 |
Why?
| | Cholesterol Esters | 1 | 2011 | 9 | 0.020 |
Why?
| | Bone Matrix | 1 | 2011 | 6 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 4447 | 0.020 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 35 | 0.020 |
Why?
| | Biological Transport | 1 | 2012 | 375 | 0.020 |
Why?
| | Serum | 1 | 2011 | 57 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 553 | 0.020 |
Why?
| | Molecular Structure | 1 | 2012 | 447 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 356 | 0.020 |
Why?
| | Diet, High-Fat | 1 | 2012 | 225 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2014 | 448 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2012 | 161 | 0.020 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 132 | 0.020 |
Why?
| | Epididymis | 1 | 2010 | 9 | 0.020 |
Why?
| | Feces | 1 | 2012 | 373 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 6434 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2010 | 160 | 0.020 |
Why?
| | Stromal Cells | 1 | 2009 | 97 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 158 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 56 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 93 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 935 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 237 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 4675 | 0.020 |
Why?
| | ATP Binding Cassette Transporter 1 | 1 | 2008 | 10 | 0.020 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2008 | 13 | 0.020 |
Why?
| | Cytokines | 1 | 2016 | 1858 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 433 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 16 | 0.020 |
Why?
| | Dextran Sulfate | 1 | 2008 | 70 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 2750 | 0.020 |
Why?
| | PPAR alpha | 1 | 2007 | 52 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2008 | 123 | 0.020 |
Why?
| | Collagen | 1 | 2010 | 415 | 0.020 |
Why?
| | Sporothrix | 1 | 2007 | 3 | 0.020 |
Why?
| | Paracoccidioides | 1 | 2007 | 2 | 0.020 |
Why?
| | Pigments, Biological | 1 | 2007 | 13 | 0.020 |
Why?
| | Blastomyces | 1 | 2007 | 7 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 2007 | 27 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 65 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2008 | 268 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2262 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2007 | 69 | 0.020 |
Why?
| | Lipid Metabolism Disorders | 1 | 2006 | 2 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 125 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2006 | 19 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2008 | 505 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2006 | 42 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2010 | 469 | 0.020 |
Why?
| | PPAR gamma | 1 | 2008 | 185 | 0.020 |
Why?
| | Receptors, Leptin | 1 | 2006 | 25 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 52 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2008 | 155 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2010 | 439 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 475 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2006 | 32 | 0.020 |
Why?
| | Response Elements | 1 | 2006 | 83 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2006 | 129 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2006 | 167 | 0.020 |
Why?
| | Octoxynol | 1 | 2005 | 11 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2005 | 14 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 154 | 0.020 |
Why?
| | Oligonucleotides, Antisense | 1 | 2006 | 100 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 49 | 0.020 |
Why?
| | Acyl-CoA Oxidase | 1 | 2005 | 2 | 0.020 |
Why?
| | Fish Oils | 1 | 2005 | 25 | 0.020 |
Why?
| | Ethanolaminephosphotransferase | 1 | 2005 | 1 | 0.020 |
Why?
| | Glycerol-3-Phosphate O-Acyltransferase | 1 | 2005 | 1 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2005 | 120 | 0.020 |
Why?
| | Thinness | 1 | 2005 | 87 | 0.020 |
Why?
| | Serine | 1 | 2005 | 125 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2006 | 299 | 0.020 |
Why?
| | Serine C-Palmitoyltransferase | 1 | 2004 | 7 | 0.020 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2004 | 8 | 0.020 |
Why?
| | Sphingomyelins | 1 | 2004 | 28 | 0.020 |
Why?
| | Acyl Coenzyme A | 1 | 2004 | 29 | 0.020 |
Why?
| | Echocardiography | 1 | 2007 | 565 | 0.020 |
Why?
| | Glycerol | 1 | 2005 | 86 | 0.020 |
Why?
| | Palmitic Acid | 1 | 2004 | 36 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2005 | 327 | 0.020 |
Why?
| | Catalysis | 1 | 2005 | 299 | 0.020 |
Why?
| | Receptors, Adrenergic, beta-3 | 1 | 2004 | 3 | 0.020 |
Why?
| | Homozygote | 1 | 2005 | 186 | 0.020 |
Why?
| | Plasmids | 1 | 2005 | 346 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2006 | 176 | 0.020 |
Why?
| | Uncoupling Protein 1 | 1 | 2004 | 16 | 0.020 |
Why?
| | Cysteine | 1 | 2005 | 173 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2009 | 695 | 0.010 |
Why?
| | Adult | 2 | 2021 | 30822 | 0.010 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2004 | 14 | 0.010 |
Why?
| | Fats | 1 | 2004 | 12 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2005 | 174 | 0.010 |
Why?
| | Trans-Activators | 1 | 2006 | 369 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2004 | 149 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 402 | 0.010 |
Why?
| | Ion Channels | 1 | 2004 | 123 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 413 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 205 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2003 | 45 | 0.010 |
Why?
| | Epitopes | 1 | 2005 | 438 | 0.010 |
Why?
| | Glucose Transporter Type 4 | 1 | 2003 | 36 | 0.010 |
Why?
| | Body Temperature | 1 | 2004 | 211 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2006 | 617 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1001 | 0.010 |
Why?
| | Transfection | 1 | 2005 | 868 | 0.010 |
Why?
| | Muscles | 1 | 2004 | 328 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1060 | 0.010 |
Why?
| | Lipoproteins, VLDL | 1 | 2002 | 21 | 0.010 |
Why?
| | Protein Conformation | 1 | 2005 | 822 | 0.010 |
Why?
| | Hydroxymethylglutaryl CoA Reductases | 1 | 2002 | 11 | 0.010 |
Why?
| | Vacuoles | 1 | 2002 | 33 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 2002 | 57 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2004 | 219 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1244 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2002 | 141 | 0.010 |
Why?
| | Phylogeny | 1 | 2004 | 806 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2002 | 754 | 0.010 |
Why?
| | Eating | 1 | 2002 | 349 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2002 | 573 | 0.010 |
Why?
| | Body Mass Index | 1 | 2005 | 1974 | 0.010 |
Why?
|
|
Miyazaki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|